The Stanford Cancer Institute is pleased to name Melissa Bondy as the new Associate Director of Population Sciences.
Image courtesy of Getty Images
Stanford Cancer Institute
Translating Stanford discoveries into individualized cancer care
Every day, people living with cancer come to Stanford for help, hope and healing.
The Future of Cancer
The SCI is focused on pushing the limits of what we can do and what we know. The only way to really advance our knowledge is to push forward in laboratories, keep thinking about novel approaches, novel mechanisms. We cannot stand still.
National Cancer Institute Designation
The Stanford Cancer Institute has been designated a Comprehensive Cancer Center by the National Cancer Institute, a part of the National Institutes of Health and the world’s leading cancer research organization.
Designation as a Comprehensive Cancer Center signifies that the Stanford Cancer Institute maintains the highest level of scientific rigor, institutional support and coordination for the complete range of cancer-related research, including basic, translational, clinical and population-based science. The designation is recognition of the institute’s robust and integrated programs encompassing laboratory research, clinical care and community outreach and education.
The Institute’s mission is to support and coordinate the wide range of cancer-related activities — in basic, translational, clinical and population-based science — occurring at Stanford University, Stanford Health Care and Lucile Packard Children’s Hospital Stanford. Its over 450 members include scientists and physicians from a wide range of disciplines, all collaborating to translate research advances into improved cancer treatments.
-
Tanning salons cluster in gay neighborhoods in large U.S. cities, study finds
Neighborhoods with more gay and bisexual men are twice as likely to have indoor tanning salons, Stanford researchers have found. Further research is needed to learn whether the industry specifically targets this population.
-
Drug combo lengthens lifespan of women with common breast cancer
The results of a phase-3 clinical trial led by a Stanford researcher showed that two targeted treatments can extend the lifespan and delay the need for chemotherapy in women with a common type of metastatic breast cancer.
-
Brain tumors form synapses with healthy neurons, Stanford-led study finds
Tumors called high-grade gliomas wire themselves into the healthy brain, receiving and interpreting electrical signals from normal neurons, a Stanford study has found.
Cancer Clinical Trials
Stanford Cancer Institute offers leading edge research and compassionate care with over 250 actively recruiting clinical trials, investigating a broad spectrum of new diagnostic, prevention and treatment strategies.